Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 6/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.54 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.46 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9135579 | 0.87 | MAOA (0.58) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL9136777 | 0.85 | MAOA (0.56) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL5579503 | 0.81 | CYP3A4 (0.62) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL30346466 | 0.80 | MAOA (0.74) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL28683594 | 0.80 | MAOA (0.74) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL8461775 | 0.80 | MAOA (0.50) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL1858144 | 0.76 | MGAM (0.67) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| Lachnone A SCHEMBL30163008 | 0.76 | ALDH1A1 (0.53) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL3730245 | 0.76 | MAPT (0.51) | MAPTMEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL4757017 | 0.76 | LMNA (0.61) | MAPTMEN1CYP3A4ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240350391-A1 | COSMETIC COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2024-10-24 | — | — | US | claimed |
| EP-4392012-A1 | COSMETIC COMPOSITIONS | The Boots Company PLC (GB) | 2024-07-03 | — | — | EP | claimed |
| WO-2023025416-A1 | COSMETIC COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2023-03-02 | — | — | WO | claimed |
| EP-4140473-A1 | COSMETIC COMPOSITIONS | The Boots Company plc (GB) | 2023-03-01 | — | — | EP | claimed |
| US-20210244635-A1 | ENZYMATIC MOLECULE MIMICKING ANTI-OXIDANT ACTIVITY | BIONUCLEI (FR) | 2021-08-12 | — | — | US | claimed |
| EP-3801058-A1 | ENZYMATIC MOLECULE MIMICKING ANTI-OXIDANT ACTIVITY | Bionuclei (FR) | 2021-04-14 | — | — | EP | claimed |
| EP-3145592-B1 | SKIN CARE COMPOSITION | BOOTS CO PLC (GB) | 2020-12-02 | — | — | EP | claimed |
| US-10335357-B2 | Skin care composition | THE BOOTS COMPANY PLC (GB) | 2019-07-02 | — | — | US | claimed |
| US-20170112758-A1 | WATER-IN-OIL EMULSION FOR SKIN CARE | THE BOOTS COMPANY PLC (GB) | 2017-04-27 | — | — | US | claimed |
| US-20170112744-A1 | Skin Care Composition | THE BOOTS COMPANY PLC (GB) | 2017-04-27 | — | — | US | claimed |
| EP-3154508-A1 | WATER-IN-OIL EMULSION FOR SKIN CARE | The Boots Company PLC (GB) | 2017-04-19 | — | — | EP | claimed |
| EP-3145592-A1 | SKIN CARE COMPOSITION | The Boots Company PLC (GB) | 2017-03-29 | — | — | EP | claimed |
| WO-2015170063-A1 | WATER-IN-OIL EMULSION FOR SKIN CARE | THE BOOTS COMPANY PLC (GB) | 2015-11-12 | — | — | WO | claimed |
| WO-2015170064-A1 | SKIN CARE COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2015-11-12 | — | — | WO | claimed |
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | THE BOOTS COMPANY PLC (GB) | 2026-04-07 | — | — | US | disclosed |
| WO-2026046854-A1 | PEPTIDE CONTAINING HYDROGEL COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2026-03-05 | — | — | WO | disclosed |
| WO-2025215346-A1 | SKIN WOUND TREATMENT | THE BOOTS COMPANY PLC (GB) | 2025-10-16 | — | — | WO | disclosed |
| EP-1732913-A1 | CHROMONE COMPLEXES | MERCK PATENT GmbH (DE) | 2006-12-20 | — | — | EP | disclosed |
| CN-1835940-A | Chromen-4-one derivatives | MERCK PATENT GMBH (DE) | 2006-09-20 | — | — | CN | disclosed |
| WO-2005097772-A1 | CHROMONE COMPLEXES | MERCK PATENT GMBH (DE) | 2005-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | SRRM2, SGTA, QARS1 | MAPT 4754/4885MEN1 4787/4885CYP3A4 4812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.